Rasmanis G, Vesterqvist O, Gréen K, Edhag O, Henriksson P
Department of Medicine, Huddinge Hospital, Sweden.
Lancet. 1988 Jul 30;2(8605):245-7. doi: 10.1016/s0140-6736(88)92537-8.
Thromboxane and prostacyclin formation were monitored in twenty patients with acute myocardial infarction. Ten received 500 mg acetylsalicylic acid (ASA) orally starting 12 h after admission and then intermittently every third day for one month; the other ten did not receive ASA or any other drug known to interfere with the synthesis of prostanoids. In the ASA group thromboxane formation, initially raised, fell rapidly and remained low. In the control group thromboxane formation decreased very slowly and was not normal by the end of the study period. Prostacyclin formation seemed identical in the two groups. Thus intermittent ASA, in this dosage, efficiently inhibited the enhanced thromboxane formation in acute myocardial infarction without interfering with prostacyclin formation.
对20例急性心肌梗死患者的血栓素和前列环素生成情况进行了监测。10例患者在入院12小时后开始口服500毫克乙酰水杨酸(ASA),然后每隔三天间歇服用一次,持续一个月;另外10例患者未接受ASA或任何其他已知会干扰前列腺素合成的药物。在ASA组中,血栓素生成最初升高,随后迅速下降并维持在低水平。在对照组中,血栓素生成下降非常缓慢,在研究期结束时仍未恢复正常。两组的前列环素生成情况似乎相同。因此,这种剂量的间歇性ASA可有效抑制急性心肌梗死中增强的血栓素生成,而不干扰前列环素生成。